Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 28:12:684220.
doi: 10.3389/fendo.2021.684220. eCollection 2021.

Liver Proteome Profile of Growth Restricted and Appropriately Grown Newborn Wistar Rats Associated With Maternal Undernutrition

Affiliations

Liver Proteome Profile of Growth Restricted and Appropriately Grown Newborn Wistar Rats Associated With Maternal Undernutrition

Polyxeni-Maria Sarli et al. Front Endocrinol (Lausanne). .

Abstract

Background: Fetal growth restriction (FGR) has been associated with adverse perinatal outcomes and epigenetic modifications that impact gene expression leading to permanent changes of fetal metabolic pathways and thereby influence development of disease in childhood and adult life. In this study, we investigated the result of maternal food restriction on liver protein expression in Wistar male newborn pups.

Materials & methods: Ten (n = 10) timed pregnant Wistar rats on their 14th day of gestation were randomly assigned to either control (n = 4) or food restricted group (n = 6). The control group had ad libitum access to food. In the food restricted group, maternal diet was limited in a moderate fashion (50%) from day 15 of pregnancy until delivery. All rats delivered spontaneously on day 21 and newborn pups were immediately weighed. Pups born to normally nourished mothers were considered as controls, while pups born to food restricted mothers were subdivided into two groups, based on their birth weight: growth restricted (FGR) and appropriately grown (non-FGR). Rats were euthanized immediately after birth and liver tissues of 11 randomly selected male offspring (FGR n = 4, non-FGR n = 4, control n = 3) were collected and analyzed using quantitative proteomics.

Results: In total 6,665 proteins were profiled. Of these, 451 and 751 were differentially expressed in FGR and non-FGR vs. control, respectively, whereas 229 proteins were commonly expressed. Bioinformatics analysis of the differentially expressed proteins (DEPs) in FGR vs. control revealed induction of the super-pathway of cholesterol biosynthesis and inhibition of thyroid hormone metabolism, fatty acid beta oxidation and apelin liver signaling pathway. Analysis of DEPs in non-FGR vs. control groups showed inhibition of thyroid hormone metabolism, fatty acid beta oxidation, and apelin liver signaling pathway.

Conclusion: This study demonstrates the impact of prenatal food restriction on the proteomic liver profile of FGR and non-FGR offspring underlying the importance of both prenatal adversities and birth weight on liver-dependent postnatal disease.

Keywords: FGR; fetal programming; food restriction; liver proteomics; metabolic disorders.

PubMed Disclaimer

Conflict of interest statement

SG is Founder, President, and CEO of Proteas Bioanalytics Inc., BioLabs at the Lundquist Institute, 1124 West Carson Street, MRL Building, 3rd Floor, Torrance, CA 90502. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Experimental design of the study.
Figure 2
Figure 2
Principal component analysis (PCA) of all quantified proteins revealed that liver of fetal growth restricted pups had a heterogeneous proteomic profile compared to non-FGR ones.
Figure 3
Figure 3
Venn diagram of common Differentially expressed proteins in FGR vs. Control and non-FGR vs. Control group.
Figure 4
Figure 4
Ingenuity Pathway Analysis of DEPs between FGR vs. Control group. Induction of the super pathway of cholesterol biosynthesis. (z = 2.2, p = 1.5e-4).
Figure 5
Figure 5
Ingenuity Pathway Analysis of DEPs between FGR vs. Control group. Inhibition of thyroid hormone metabolism. (z = -2.0, p = 4.6e-3).
Figure 6
Figure 6
Ingenuity Pathway Analysis of DEPs between FGR vs. Control group. Inhibition of fatty acid beta oxidation. (z =2.0, p = 2.7e-3).
Figure 7
Figure 7
Ingenuity Pathway Analysis of DEPs between FGR vs. Control group. Inhibition of apelin liver signaling pathway. (z = −2.2, p = 8.5e-5).
Figure 8
Figure 8
Ingenuity Pathway Analysis of differentially expressed proteins in non-FGR compared to control group showed inhibition of thyroid hormone metabolism (z=2.0, p = 2.5e-2), fatty acid beta oxidation (z =2.0, p = 1.6e-2) and apelin liver signaling pathway (z = −2.0, p = 6.7e-3). Apelin inhibits liver regeneration while promoting hepatic fibrosis upon injury. It also has an anti-insulin resistance properties.

Similar articles

Cited by

References

    1. Gardosi J, Madurasinghe V, Williams M, Malik A, Francis A. Maternal and Fetal Risk Factors for Stillbirth: Population Based Study. BMJ (2013) 346(jan24 3):f108–8. 10.1136/bmj.f108 - DOI - PMC - PubMed
    1. Miller SL, Huppi PS, Mallard C. The Consequences of Fetal Growth Restriction on Brain Structure and Neurodevelopmental Outcome: Fetal Growth Restriction: Brain Structure and Function. J Physiol (2016) 594(4):807–23. 10.1113/JP271402 - DOI - PMC - PubMed
    1. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS. Type 2 (non-Insulin-Dependent) Diabetes Mellitus, Hypertension and Hyperlipidaemia (Syndrome X): Relation to Reduced Fetal Growth. Diabetologia (1993) 36(1):62–7. 10.1007/BF00399095 - DOI - PubMed
    1. Barker DJ, Osmond C. Infant Mortality, Childhood Nutrition, and Ischaemic Heart Disease in England and Wales. Lancet Lond Engl (1986) 1(8489):1077–81. 10.1016/S0140-6736(86)91340-1 - DOI - PubMed
    1. Eleftheriades M, Creatsas G, Nicolaides K. Fetal Growth Restriction and Postnatal Development. Ann N Y Acad Sci (2006) 1092(1):319–30. 10.1196/annals.1365.047 - DOI - PubMed

Publication types